Antonio Ferronato

1.3k total citations
36 papers, 730 citations indexed

About

Antonio Ferronato is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Antonio Ferronato has authored 36 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 14 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Antonio Ferronato's work include Inflammatory Bowel Disease (19 papers), Microscopic Colitis (14 papers) and Biosimilars and Bioanalytical Methods (9 papers). Antonio Ferronato is often cited by papers focused on Inflammatory Bowel Disease (19 papers), Microscopic Colitis (14 papers) and Biosimilars and Bioanalytical Methods (9 papers). Antonio Ferronato collaborates with scholars based in Italy, United States and Brazil. Antonio Ferronato's co-authors include Giacomo Carlo Sturniolo, R. D’Incà, Vincenza Di Leo, Anna D’Odorico, Maria Grazia Vettorato, E. Dal Pont, Walter Fries, Diego Martines, Manoel Antônio dos Santos and Denise Siqueira Péres and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Scientific Reports.

In The Last Decade

Antonio Ferronato

33 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Ferronato Italy 13 292 275 217 138 123 36 730
Omar I. Saadah Saudi Arabia 18 394 1.3× 333 1.2× 338 1.6× 59 0.4× 123 1.0× 115 1.0k
Michael Cosgrove United Kingdom 11 149 0.5× 112 0.4× 148 0.7× 128 0.9× 62 0.5× 31 558
Grzegorz Telega United States 13 271 0.9× 236 0.9× 244 1.1× 53 0.4× 83 0.7× 30 677
Annette Findeisen Germany 10 165 0.6× 181 0.7× 156 0.7× 84 0.6× 35 0.3× 13 498
Gigi Veereman Belgium 14 376 1.3× 159 0.6× 236 1.1× 161 1.2× 101 0.8× 35 700
Shannan Grant Canada 8 389 1.3× 279 1.0× 221 1.0× 93 0.7× 25 0.2× 30 719
Prévost Jantchou Canada 16 600 2.1× 276 1.0× 384 1.8× 75 0.5× 161 1.3× 55 1.1k
G.C. Sturniolo Italy 14 400 1.4× 269 1.0× 297 1.4× 72 0.5× 47 0.4× 28 827
Taina Routi Finland 13 72 0.2× 147 0.5× 326 1.5× 127 0.9× 37 0.3× 18 789
Sharyle Fowler Canada 13 373 1.3× 281 1.0× 227 1.0× 23 0.2× 240 2.0× 51 774

Countries citing papers authored by Antonio Ferronato

Since Specialization
Citations

This map shows the geographic impact of Antonio Ferronato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Ferronato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Ferronato more than expected).

Fields of papers citing papers by Antonio Ferronato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Ferronato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Ferronato. The network helps show where Antonio Ferronato may publish in the future.

Co-authorship network of co-authors of Antonio Ferronato

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Ferronato. A scholar is included among the top collaborators of Antonio Ferronato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Ferronato. Antonio Ferronato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bevilacqua, Nazario, Roberto Gabbiadini, Cristina Bezzio, et al.. (2024). P535 Effectiveness of upadacitinib in patients with Ulcerative Colitis: a real-life, multicenter, Italian report. Journal of Crohn s and Colitis. 18(Supplement_1). i1045–i1046. 1 indexed citations
2.
Mocci, Giammarco, Graziella Orrù, Giorgia Bodini, et al.. (2024). P1127 Diagnostic delay and economic burden in IBD: a multicenter italian experience in patients treated with biologics. Journal of Crohn s and Colitis. 18(Supplement_1). i2007–i2007.
3.
Russo, Michele, K. Rodriguez-Castro, Marilisa Franceschi, et al.. (2023). Appropriateness of Proton Pump Inhibitor Prescription Evaluated by Using Serological Markers. International Journal of Molecular Sciences. 24(3). 2378–2378. 1 indexed citations
4.
Mocci, Giammarco, Arianna Cingolani, Carla Felice, et al.. (2023). Adalimumab biosimilar ABP 501 is equally effective and safe in long-term management of inflammatory bowel diseases patients when used as first biologic treatment or as replace of the ADA originator for a non-medical reason. SHILAP Revista de lepidopterología. 2. 1218228–1218228. 1 indexed citations
5.
Mario, Francesco Di, Pellegrino Crafa, Marilisa Franceschi, et al.. (2021). Low Levels of Gastrin 17 are Related with Endoscopic Findings of Esophagitis and Typical Symptoms of GERD. Journal of Gastrointestinal and Liver Diseases. 30(1). 25–29. 6 indexed citations
6.
Barberio, Brigida, Fabiana Zingone, Antonio Ferronato, et al.. (2021). Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator. Scientific Reports. 11(1). 10368–10368. 28 indexed citations
7.
Barberio, Brigida, Fabiana Zingone, Lorenzo Bertani, et al.. (2020). P468 Switching from adalimumab originator to ABP 501 biosimilar: a multicentre North Italian study. Journal of Crohn s and Colitis. 14(Supplement_1). S414–S414. 1 indexed citations
8.
Tursi, Antonio, Marilisa Franceschi, Leonardo Allegretta, et al.. (2018). Effectiveness and Safety of Pylera® in Patients Infected by <b><i>Helicobacter Pylori</i></b>: A Multicenter, Retrospective, Real Life Study. Digestive Diseases. 36(4). 264–268. 20 indexed citations
9.
Scribano, Maria Lia, Claudio Papi, Francesco Costa, et al.. (2018). Management of ulcerative colitis in a real-life setting: An Italian multicenter, prospective, observational AIGO study. Digestive and Liver Disease. 51(3). 346–351. 5 indexed citations
10.
Tursi, Antonio, Francesco Di Mario, Marilisa Franceschi, et al.. (2017). New bismuth‐containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice. Helicobacter. 22(3). 42 indexed citations
11.
Zanetti, María Lúcia, Liudmila Miyar Otero, Maria Cristina Foss‐Freitas, et al.. (2012). Atendimento ao paciente diabético utilizando o protocolo Staged Diabetes management: relato de experiência. SHILAP Revista de lepidopterología. 19(4). 253–260. 1 indexed citations
12.
Punzi, Leonardo, Roberto Stramare, R. D’Incà, et al.. (2011). The prevalence of radiographic sacroiliitis in patients affected by inflammatory bowel disease with inflammatory low back pain. Reumatismo. 56(2). 110–3. 4 indexed citations
13.
D’Incà, R., et al.. (2009). Articular manifestations in inflammatory bowel disease patients: A prospective study. Digestive and Liver Disease. 41(8). 565–569. 31 indexed citations
14.
D’Incà, R., Fabio Pomerri, Maria Grazia Vettorato, et al.. (2007). Interaction between rifaximin and dietary fibre in patients with diverticular disease. Alimentary Pharmacology & Therapeutics. 25(7). 771–779. 51 indexed citations
15.
Péres, Denise Siqueira, Manoel Antônio dos Santos, María Lúcia Zanetti, & Antonio Ferronato. (2007). Difficulties of diabetic patients in the illness control: feelings and behaviors. Revista Latino-Americana de Enfermagem. 15(6). 1105–1112. 42 indexed citations
16.
Zanetti, María Lúcia, Liudmila Miyar Otero, Maria Cristina Foss‐Freitas, et al.. (2006). Atendimento ao paciente diabético utilizando o protocolo Staged Diabetes Management: relato de experiência. Revista Brasileira em Promoção da saúde. 253–260. 10 indexed citations
17.
D’Incà, R., E. Dal Pont, Vincenza Di Leo, et al.. (2006). Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. International Journal of Colorectal Disease. 22(4). 429–437. 181 indexed citations
18.
Sturniolo, Giacomo Carlo, Vincenza Di Leo, Antonio Ferronato, Anna D’Odorico, & R. D’Incà. (2001). Zinc Supplementation Tightens “Leaky Gut” in Crohn’s Disease. Inflammatory Bowel Diseases. 7(2). 94–98. 140 indexed citations
19.
Sturniolo, Giacomo Carlo, Vincenza Di Leo, Michela Barollo, et al.. (2000). The many functions of zinc in inflammatory conditions of the gastrointestinal tract. The Journal of Trace Elements in Experimental Medicine. 13(1). 33–39. 18 indexed citations
20.
D’Odorico, Anna, et al.. (2000). Influence of Disease Site and Activity on Peripheral Neutrophil Function in Inflammatory Bowel Disease. Digestive Diseases and Sciences. 45(8). 1594–1600. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Omar I. Saadah Breakdown of academic impact, for papers by Michael Cosgrove Breakdown of academic impact, for papers by Grzegorz Telega Breakdown of academic impact, for papers by Annette Findeisen Breakdown of academic impact, for papers by Gigi Veereman Breakdown of academic impact, for papers by Shannan Grant Breakdown of academic impact, for papers by Prévost Jantchou Breakdown of academic impact, for papers by G.C. Sturniolo Breakdown of academic impact, for papers by Taina Routi Breakdown of academic impact, for papers by Sharyle Fowler
Rankless by CCL
2026